About the Authors
- Sara Lodi
-
* E-mail: slodi@hsph.harvard.edu
Affiliation Instituto de Salud Carlos III, Madrid, Spain
- Martin Fisher
-
Affiliation Brighton and Sussex University Hospitals National Health Service Trust, Brighton, United Kingdom
- Andrew Phillips
-
Affiliation University College of London, London, United Kingdom
- Andrea De Luca
-
Affiliation University Division of Infectious Diseases, University Hospital of Siena, Siena, Italy
- Jade Ghosn
-
Affiliation Université Paris Descartes, EA 3620, Paris, France
- Ruslan Malyuta
-
Affiliation Perinatal Prevention of AIDS Initiative, Odessa, The Ukraine
- Robert Zangerle
-
Affiliation Innsbruck Medical University, Innsbruck, Austria
- Santiago Moreno
-
Affiliation Hospital Ramon y Cajal, Madrid, Spain
- Philippe Vanhems
-
Affiliation Edouard Herriot Hospital, Lyon, and Universite' de Lyon 1, Lyon, France
- Faroudy Boufassa
-
Affiliation Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of HIV and STI Team, Le Kremlin-Bicetre, France
- Marguerite Guiguet
-
Affiliation INSERM and UPMC Univ Paris 06, UMR S 943, Paris, France
- Kholoud Porter
-
Affiliation MRC Clinical Trials Unit at University College London, London, United Kingdom
- for CASCADE Collaboration in EuroCoord
-
¶Membership of the CASCADE Collaboration is provided in the Acknowledgments.
Competing Interests
KP has received an honorarium from Tibotec. AP has received fees for consultancy for Gilead Sciences, GSK Biologicals, KP 360; speaker fees from Gilead; funds for research from BMS; Advisory Board membership with Abbvie. JG has received fees for consulting from Gilead Sciences, Bristol Myers Squibb, Merck Sharp Dohme Chibret, Janssen, Merck Sharp Dohme Chibret and Viiv. PV has received consultancy from consulting for Sanofi Pasteur. AdL has received fees for consulting from Gilead, Jansen, Siemens diagnostics, Abbott Virology and ViiV Healthcare. MF has received honoraria, speaker fees, or funding to attend conferences from: AbbVie, Bristol Myers Squibb, Gilead, Janssen, Merck, and Viiv. No other competing interests to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SL MF KP. Wrote the paper: SL KP. Analysis and interpretation: SL MF AP ADL JG RM RZ SM PV FB MG KP. Obtained funding: KP. Statistical analyses: SL.